Therefore, we hypothesized that in diabetic nephropathy, levels of the pro-inflammatory/fibrotic marker CHI3L1 would be elevated, while levels of the pro-resolving mediator MaR1 would be altered as part of a compensatory response. The gene discussed is CHI3L1; the disease is diabetic kidney disease.